Forum for Science, Industry and Business

Enzyme protein eight times more effective against pain than morphine

The enzyme protein found naturally in the body alleviated pain eight times more effectively than morphine. Research findings are published this week as the cover story of the esteemed Neuron journal.

Professor Pirkko Vihko from the Department of Biological and Environmental Sciences of the University of Helsinki has conducted research on the Prostatic Acid Phosphatase (PAP) enzyme for more than 30 years. As the name indicates, the prostate contains plenty of this enzyme.

Last year, Vihko's research team described the membrane form of the enzyme and showed that it is present not only in the prostate, but in many other cells and organs as well. The PAP enzyme exists, for example, in pain-sensing nerves, but it has disappeared from damaged nerves.

For the research project presented in the Neuron journal, Vihko and her team prepared a knockout mouse model with the PAP enzyme knocked out. Together with Mark Zylka's team from the University of North Carolina they showed that these mice had an increased sensitivity for pain caused by inflammation and neural damage. The reason for the sensitivity was the lack of the PAP enzyme. Enzyme protein replacement treatment removed pain effectively – eight times more so than morphine. Clinical research will begin next.

Research teams also determined the mechanism that the acid phosphatase of the prostate uses to regulate pain alleviation. In an organism, the enzyme generates adenosine that controls the experience of pain through the adenosine receptor. Vihko’s team will prepare new publications that describe the entirely new effective areas of the enzyme.

Kirsikka Mattila | alfa
Further information:
http://www.neuron.org/

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...